Guías Clínicas
99
Guías tam izaje, d iagn óstico y tratam ien to de l hepa toca rcinoma - Sociedad Chilena de Gastroenterología
(CLIP) investigators. A New Prognostic
System for Hepatocellular Carcinoma:
a Retrospective Study of 435 patients.
Hepatology. 1998;28:751-5.
79.- Chevret S, Trinchet JC, Mathieu D,
Rached AA, Beaugrand M, Chastang
C. A New Prognostic Classification for
Predicting Survival in Patients with
Hepatocellular Carcinoma. J Hepatol.
1999;31:133-41.
80.- Llovet J, Brú C, Bruix J. Prognosis of
Hepatocellular Carcinoma: The BCLC
Staging Classification. Semin Liver Dis.
1999;19:329-38.
81.- Kee KM, Wang JH, Lin CY, Wang CC,
Cheng YF, Lu SN. Validation of the
7th Edition TNM Staging System for
Hepatocellular Carcinoma: An Analysis
of 8,828 Patients in a Single Medical
Center. Dig Dis Sci. 2013;58:2721-8.
82.- Leung TWT, Tang AMY, Zee B,
Lau WY, Lai PBS, Leung KL, et al.
Construction of the Chinese University
Prognostic Index for Hepatocellular
Carcinoma and Comparison with the
TNM Staging System, the Okuda
Staging System, and the Cancer of the
Liver Italian Program staging system:
A Study Based on 926 patients. Cancer.
2002;94:1760-9.
83.- Kudo M, Chung H, Osaki Y. Prognostic
Staging System for Hepatocellular
Carcinoma (CLIP score): Its Value
and Limitations, and a Proposal for
a New Staging System, The Japan
Integrated Staging Score (JIS score). J
Gastroenterol. 2003;38:207-15.
84.- Omagari K, Honda S, Kadokawa Y,
Isomoto H, Takeshima F, Hayashida K,
et al. Preliminary Analysis of a Newly
Proposed Prognostic Scoring System
(SLiDe score) for Hepatocellular
Carcinoma. J Gastroenterol Hepatol.
2004;19:805-11.
85.- Tateishi R, Yoshida H, Shiina S,
Imamura H, Hasegawa K, Teratani T,
et al. Proposal of a New Prognostic
Model for Hepatocellular Carcinoma:
An Analysis of 403 Patients. Gut.
2005;54:419-25.
86.- Toyoda H, Kumada T, Osaki Y, Oka
H, Urano F, Kudo M, et al. Staging
Hepatocellular Carcinoma by a Novel
Scoring System (BALAD Score) Based
on Serum Markers. Clin Gastroenterol
Hepatol. 2006;4:1528-36.
87.- Kitai S, Kudo M, Minami Y, Uesshima
K, Chung H, Hagiwara S, et al. A
New Prognostic Staging System for
Hepatocellular Carcinoma: Value
of the Biomarker Combined Japan
Integrated Staging Score. Intervirology.
2008;51:86-94.
88.- Cho C, Gonen M, Shia J, Kattan M,
Klimstra D, Jarnagin W, et al. A Novel
Prognostic Nomogram Is More Accurate
than Conventional Staging Systems for
Predicting Survival after Resection of
Hepatocellular Carcinoma. J Am Coll
Surg. 2008;206:281-91.
89.- Hsu CY, Huang YH, Hsia CY, Su
CW, Lin HC, Loong CC, et al. A New
Prognostic Model for Hepatocellular
Carcinoma Based on Total Tumor
Volume: The Taipei Integrated Scoring
System. J Hepatol. 2010;53:108-17.
90.- Yang T, Zhang H, Lu J, Yang L, Yang G,
Wu M, et al. A New Staging System for
Resectable Hepatocellular Carcinoma:
Comparison with Six Existing Staging
Systems in a Large Chinese Cohort. J
Cancer Res Clin Oncol. 2011;137:739-
50.
91.- Yau T, Tang VYF, Yao TJ, Fan ST, Lo
CM, Poon RTP. Development of Hong
Kong Liver Cancer Staging System
with Treatment Stratification for
Patients with Hepatocellular Carcinoma.
Gastroenterology. 2014;146:1691-700.
92.- Liu P-H, Hsu C-Y, Hsia C-Y, Lee Y-H,
Huang Y-H, Su C-W, et al. Proposal and
Validation of a New Model to Estimate
Survival for Hepatocellular Carcinoma
Patients. Eur J Cancer. 2016;63:25-33.
93.- Farinati F, Vitale A, Spolverato G,
Pawlik TM, Huo T La, Lee YH, et al.
Development and Validation of a New
Prognostic System for Patients with
Hepatocellular Carcinoma. PLoS Med.
2016;13:1-18.
94.- Chan SL, Mo FKF, Johnson PJ,
Liem GS, Chan TC, Poon MC, et
al. Prospective Validation of the
Chinese University Prognostic Index
and Comparison with Other Staging
Systems for Hepatocellular Carcinoma
in an Asian Population. J Gastroenterol
Hepatol. 2011;26:340-7.
95.- Hsu CY, Hsia CY, Huang YH, Su
CW, Lin HC, Lee PC, et al. Selecting
an Optimal Staging System for
Hepatocellular Carcinoma: Comparison
of 5 Currently Used Prognostic Models.
Cancer. 2010;116:3006-14.
96.- Zhang JF, Shu ZJ, Xie CY, Li Q, Jin XH,
Gu W, et al. Prognosis of Unresectable
Hepatocellular Carcinoma: Comparison
of Seven Staging Systems (TNM,
Okuda, BCLC, CLIP, CUPI, JIS,
CIS) in a Chinese Cohort. PLoS One.
2014;9(3):e88182.
97.- Liu PH, Hsu CY, Hsia CY, Lee YH,
Su CW, Huang YH, et al. Prognosis of
Hepatocellular Carcinoma: Assessment
of Eleven Staging Systems. J Hepatol.
2016;64:601-8.
98.- Kudo M, Chung H, Haji S, Osaki Y,
Oka H, Seki T, et al. Validation of a
New Prognostic Staging System for
Hepatocellular Carcinoma: The JIS
Score Compared with the CLIP Score.
Hepatology. 2004;40:1396-405.
99.- Chung H, Kudo M, Takahashi S,
Hagiwara S, Sakaguchi Y, Inoue T, et al.
Comparison of Three Current Staging
Systems for Hepatocellular Carcinoma:
Japan Integrated Staging Score, New
Barcelona Clinic Liver Cancer Staging
Classification, and Tokyo Score. J
Gastroenterol Hepatol. 2008;23:445-52.
100.- Kitai S, Kudo M, Izumi N, Kaneko
S, Ku Y, Kokudo N, et al. Validation
of Three Staging Systems for
Hepatocellular Carcinoma (JIS Score,
Biomarker-Combined JIS Score and
BCLC System) in 4,649 Cases from a
Japanese Nationwide Survey. Dig Dis.
2014;32:717-24.
101.- Huo T, Hsia C, Huang Y, Lin H, Lee
P, Lui W, et al. Selecting a Short-term
Prognostic Model for Hepatocellular
Carcinoma: Comparison Between the
Model for End-stage Liver Disease
(MELD), MELD-sodium, and Five
Cancer Staging Systems. J Clin
Gastroenterol. 2009;43:773-81.
102.- Kitai S, Kudo M, Minami Y, Haji S,
Osaki Y, Oka H, et al. Validation of
a New Prognostic Staging System
for Hepatocellular Carcinoma: A
Comparison of the Biomarker-Combined
Japan Integrated Staging Score, the
Conventional Japan Integrated Staging
Score and the BALAD Score. Oncology.
2008;75:83-90.
103.- Marrero JA, Fontana RJ, Barrat A,
Askari F, Conjeevaram HS, Su GL, et al.
Prognosis of Hepatocellular Carcinoma:
Gastroenterol. latinoam 2019; Vol 30, Nº 2: 64-106